SECreport

Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 29 Filed by: Pershing Edward

PROVECTUS BIOPHARMS  (PVCT) 
NASDAQ:AMEX Investor Relations: provectusbio.com/financial-overview